Benzodiazepine Treatment of Anxiety or Insomnia in Substance Abuse Patients
Corresponding Author
Domenic A. Ciraulo M.D.
From the Division of Psychiatry, Boston University School of Medicine, Boston, Mass.; Boston Medical Center, Boston, Mass.; the Psychiatry Service, VA Boston Healthcare System, Boston, Mass.
Address correspondence to Dr. Ciraulo at the Division of Psychiatry, Boston University School of Medicine, 720 Harrison Ave., Suite 914, Boston, MA 02118. E-mail: [email protected].
Address correspondence to Dr. Nace at 7777 Forest Ln., Suite B-413, Dallas, TX 75230. E-mail: [email protected].
Search for more papers by this authorCorresponding Author
Edgar P. Nace M.D.
The Department of Psychiatry and Behavioral Sciences, University of Texas Southwestern Medical School, Dallas.
Address correspondence to Dr. Ciraulo at the Division of Psychiatry, Boston University School of Medicine, 720 Harrison Ave., Suite 914, Boston, MA 02118. E-mail: [email protected].
Address correspondence to Dr. Nace at 7777 Forest Ln., Suite B-413, Dallas, TX 75230. E-mail: [email protected].
Search for more papers by this authorCorresponding Author
Domenic A. Ciraulo M.D.
From the Division of Psychiatry, Boston University School of Medicine, Boston, Mass.; Boston Medical Center, Boston, Mass.; the Psychiatry Service, VA Boston Healthcare System, Boston, Mass.
Address correspondence to Dr. Ciraulo at the Division of Psychiatry, Boston University School of Medicine, 720 Harrison Ave., Suite 914, Boston, MA 02118. E-mail: [email protected].
Address correspondence to Dr. Nace at 7777 Forest Ln., Suite B-413, Dallas, TX 75230. E-mail: [email protected].
Search for more papers by this authorCorresponding Author
Edgar P. Nace M.D.
The Department of Psychiatry and Behavioral Sciences, University of Texas Southwestern Medical School, Dallas.
Address correspondence to Dr. Ciraulo at the Division of Psychiatry, Boston University School of Medicine, 720 Harrison Ave., Suite 914, Boston, MA 02118. E-mail: [email protected].
Address correspondence to Dr. Nace at 7777 Forest Ln., Suite B-413, Dallas, TX 75230. E-mail: [email protected].
Search for more papers by this author
REFERENCES
- 1 Ciraulo DA, Sands BF, Shader RI. Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry. 1988; 145: 1501–1506.
- 2 Ciraulo DA, Barnhill JG, Greenblatt DJ, et al. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men. J Clin Psychiatry. 1988; 49(9): 333–337.
- 3 Ciraulo DA, Barnhill JG, Ciraulo AM, et al. Alterations in pharmacodynamics of anxiolytics in abstinent alcoholics: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone. J Clin Pharmacol. 1997; 37: 64–73.
- 4 Ciraulo DA, Knapp CM, LoCastro J, Greenblatt DJ, Shader RI. A benzodiazepine mood effect scale: reliability and validity determined for alcohol dependent subjects and adults with a parental history of alcoholism. Am J Drug Alcohol Abuse. In press.
- 5 Jaffe JH, Ciraulo DA, Nies A, Dixon RB, Monroe LL. Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal. Clin Pharmacol Ther. 1983; 34: 623–630.
- 6 Abi-Dargham A, Krystal JH, Anjilvel S, et al. Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I}iomazenil. Am J Psychiatry. 1998; 155(11): 1550–1555.
- 7 Behar KL, Rothman DL, Petersen KF, et al. Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry. 1999; 156(6): 952–954.
- 8
Freund G,
Ballinger WE Jr.
Decrease of benzodiazepine receptors in frontal cortex of alcoholics.
Alcohol. 1988; 5(4): 275–282.
10.1016/0741-8329(88)90065-1 Google Scholar
- 9 Sellers EM, Ciraulo DA, DuPont RL, et al. Alprazolam and benzodiazepine dependence. J Clin Psychiatry. 1993; 54(suppl 10): 64–75.
- 10 Ross HE. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction. 1993; 88: 209–218.
- 11 Mueller TI, Goldenberg IM, Gordon AL, Keller MB, Warshaw MG. Benzodiazepine use in anxiety disordered patients with and without a history of alcoholism. J Clin Psychiatry. 1996; 57: 83–89.
- 12 Lejoyeux M, Solomon J, Ades J. Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol. 1998; 33(6): 563–575.
- 13
Adinoff B.
Long-term therapy with benzodiazepines despite alcohol dependence disorder.
Am J Addict. 1992; 1(4): 288–293.
10.1111/j.1521-0391.1992.tb00354.x Google Scholar
- 14 Lydiard RB. Use of benzodiazepines by alcoholics [letter}. Am J Psychiatry. 1990; 147: 128–129.
REFERENCES
- 1 Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal: a randomized double-blind controlled trial. JAMA. 1994; 272: 519–523.
- 2
Osser DN,
Renner JA,
Bayog R.
Algorithms for the pharmacotherapy of anxiety disorders in patients with chemical abuse and dependence.
Psychiatric Annals. 1999; 29: 285–301.
10.3928/0048-5713-19990501-10 Google Scholar
- 3 Kessler RC, Crum RM, Warner LA, et al. Lifetime co-occurence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidality Survey. Arch Gen Psychiatry. 1997; 54: 313–321.
- 4 Bower RC, Cipywnyk D, D'arcy C, et al. Alcoholism, anxiety disorders, and agoraphobia. Alcohol Clin Exp Res. 1984; 8: 48–50.
- 5 Anthony JC, Warner LA, Kessler RC. Comparative epidemology of dependence on tolerance, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol. 1994; 21: 244–268.
- 6 Ciraulo DA, Sands BF, Shader RI. Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry. 1988; 145: 1501–1506.
- 7
Malcolm R,
Brady KT,
Johnston AL,
Cunningham M.
Types of benzodiazepines abused by chemically dependent inpatients.
J Psychoactive Drugs. 1993; 25: 315–319.
10.1080/02791072.1993.10472289 Google Scholar
- 8 Busto U, Sellers EM, Naranjo CA, et al. Patterns of benzodiazepine abuse and dependence Br J Addict. 1986; 81: 87–94.
- 9 Ciraulo DA, Barnhill JG, Ciraulo AM, et al. Parental alcoholism as a risk factor in benzodiazepine abuse: a pilot study. Am J Psychiatry. 1989; 146: 1333–1335.
- 10 Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse and consequences. Pharmacol Rev. 1992; 44: 151–347.
- 11 Schweizer E, Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand. 1998; 98(suppl 393): 95–101.
- 12 Kranzler HR, Burleson JA, Del Boca FK, et al. Buspirone treatment of anxious alcoholics. Arch Gen Psychiatry. 1994; 51: 720–731.
- 13 DeMartinis N, Rynn M, Rickels K, et al. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder. J Clin Psychiatry. 2000; 61: 91–94.
- 14 Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998; 155: 992–993.
- 15 MP Bowes, ed. Developing better treatment strategies for insomnia. Advances in Patient Care. CME, Inc. April 2000: 1–4.
REFERENCES
- 1 DeMartinis N, Rynn M, Rickels K, et al. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder. J Clin Psychiatry. 2000; 61: 91–94.
- 2
Lanfumey L,
Haj-Dahmane S,
Laporte AM,
Martin P,
Hamon M,
Gozlan H.
Effects of chronic diazepam treatment on pre-and postsynaptic 5-HT1A receptors in the rat brain.
Eur J Pharmacol. 1997; 323(2–3): 137–148.
10.1016/S0014-2999(97)00032-0 Google Scholar
- 3 Salzman C. An 87-year-old woman taking a benzodiazepine. JAMA. 1999; 281(12): 1121–1125.
- 4 Ciraulo DA, Sarid-Segal O. Sedative-, hypnotic-, or anxiolytic-related abuse. In: BJ Sadock, VA Sadock, eds. Comprehensive Textbook of Psychiatry. 7th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2000: 1071–1085.
- 5 Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse and consequences. Pharmacol Rev. 1992; 44: 151–347.
- 6
Rickels K,
DeMartinis N,
Aufdembrinke B.
A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder.
J Clin Psychopharmacol. 2000; 20(1): 12–18.
10.1097/00004714-200002000-00004 Google Scholar
REFERENCES
- 1 Ballenger JC. Update on anxiety disorders. Arch Intern Med. 1991; 151: 857–859.
- 2 Woods JH, Katz JL, Winger G. Use and abuse of benzodiazepines: issues relevant to prescribing. JAMA. 1988; 260(23): 3476–3480.
